Crawford Lake Capital Management, LLC Agenus Inc Transaction History

Crawford Lake Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.92 - $4.39 $1.25 Million - $2.86 Million	-652,391 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.41 - $4.4 $495,228 - $904,151	205,489 Added 45.98%	652,391 $2.66 Million
Q3 2019 Nov 14, 2019	BUY	$2.17 - $3.14 $118,594 - $171,607	54,652 Added 13.93%	446,902 $1.15 Million
Q2 2019 Aug 14, 2019	BUY	$2.53 - $3.04 $73,567 - $88,397	29,078 Added 8.01%	392,250 $1.18 Million
Q1 2019 May 15, 2019	BUY	$2.51 - $3.73 $911,561 - $1.35 Million	363,172 New	363,172 $1.08 Million

2.03M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Crawford Lake Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Crawford Lake Capital Management, LLC with notifications on news.